Sentinel Node Biopsy : the way forward Hemant Singhal MS FRCSEd FRCS(Gen) FRCSC Consultant Surgeon Northwick Park & St Marks Hospital Senior Lecturer,

Slides:



Advertisements
Similar presentations
Dr Cheung Chi Ying Genevieve
Advertisements

Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
BREAST CANCER CASE STUDY FRAZER BELL STUDENT BMS BSc APPLIED BIOMEDICAL SCIENCE.
SENTINEL LYMPH NODE BIOPSY IN COLORECTAL CARCINOMA E Leung*, J Francombe*, S Chew, PR Douglas, GL Newstead Prince of Wales Hospital, Sydney, Australia.
Contraindications to sentinel lymph node biopsy Martine Berliere GGOLFB Breast Clinic Cancer Center Cliniques Universitaires St Luc.
BREAST SENTINEL NODE LOCALISATION & BIOPSY
Surgical Pathology of Wide Local Excision of Breast
Breast Cancer in Pregnancy
Sentinel Nodes J.R.Buscombe RFH.
Current Management of the Axilla in Breast Cancer Joint Hospital Surgical Grand Round 25 th July, 2009 Princess Margaret Hospital Law Hang Sze.
An update for Illinois Nurses Elizabeth A. Peralta, MD The Breast Center at SIU Springfield, IL May 2011.
Impact of Lymph-Node Metastatic Site in Patients with Thoracic Esophageal Cancer Edited by: Kunisaki C., Makino H., Kimura J., Oshima T., Fujii S., Takagawa.
Sentinel Lymph Node procedure Intraoperative Examination Belgian Breast Meeting 14/10/2006 Daniel Faverly MD Pathology Laboratory CMP-LabPatho Centre Communautaire.
Frank P. Dawry LYMPHOSCINTIGRAPHY Sentinel node localization in Melanoma.
Sentinel Node: Practical Experience at Frimley Park Hospital RJ Morton, A Fullbrook, L Wright, JRW Hall, J Ward.
Sentinel Lymph Node Biopsy in Melanoma
Julie R. Gralow, M.D. Director, Breast Medical Oncology, Seattle Cancer Care Alliance Professor, Medical Oncology, University of Washington School of Medicine.
Radiation Safety Oversight of Surgical Procedures Involving the Use of RAM René Michel, M.S., RSO VA San Diego Healthcare System, San Diego, CA.
Dr Andrea J Howes Consultant Radiologist St Helens and Knowsley NHS Trust.
Sentinel Lymph Node Dissection (SND)
Clinical Utility of Combidex in Various Cancers
AJCC TNM Staging 7th Edition Breast Case #3
Sentinel Lymph Node Concept; and Technique of SLN Identification in Breast Cancer Patients Dr S.Gambhir Department of Nuclear Medicine S.G.P.G.I.M.SLucknow.
Breast Reconstruction Hemant Singhal FRCSEd FRCS(Gen) FRCSC Consultant Surgeon Senior Lecturer (Hon) Imperial College School Of Medicine These PowerPoint.
Breast Conservation Surgery
West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.
Neoadjuvant Chemotherapy for Ca Breast CY Choi UCH.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Breast Cancer Early detection of disease Precise Staging.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Breast conservation in Locally advanced breast cancer Department of Endocrine Surgery College of Medicine Amrita Institute of Medical Sciences Kochi, Kerala.
Treatment of Early Breast Cancer
SLN (Sentinel Lymph Node) And Breast (cancer)
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management J Nucl Med 2006; 47:616–624 報告者 : 蘇惠怡.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Background Sentinel lymph node biopsy has been recently introduced in the clinical setting because it is highly accurate in predicting the lymph node status.
In the name of God Isfahan medical school Shahnaz Aram MD.
EVALUATION OF LYMPH NODES & PATHOLOGIC EXAMINATION FOR BREAST CASES Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry.
11th Biennial Meeting of the International Gynecologic Cancer Society 11th Biennial Meeting of the International Gynecologic Cancer Society Semih Gorgulu,
The Treatment of the Axilla in the North of England Cancer Network. Henry Cain ST7 North Tyneside.
TREATMENT Mastectomy -traditionally, treatment of breast ca has been surgical -19 century, surgical treatment : local excision ~ total mastectomy : radical.
Margin evaluation in Breast Conservation Treatment Dr. C. Gopalakrishnan Nair Department of endocrine Surgery College of Medicine AIMS Kochi, Kerala These.
How are Auckland Surgeons Managing the Axilla? E Whineray Kelly, O Pellet, L Neave, J Harman, R Harman. Auckland Breast Cancer Study Group.
Sentinel Node Biopsy IRCH - AIIMS Experience
Radical Mastectomy is no longer the standard Improved adjuvant and neoadjuvant therapy Chemotherapy Endocrine therapy Radiation treatment Reconstruction.
Residents’ Journal Club Giao Q. Phan, M.D. September 4, 2014.
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
Adjuvant chemotherapy – When should surgeons recommend? Joint Hospital Surgical Grand Round Dr Lorraine Chow Ruttonjee Hospital.
Lymphoscintigraphy and SNLB in
در مرکز پزشکی هسته ای دکتر دباغ – دکتر صادقی
SLNB The RUH experience A 2014 Audit Dr M Stoddart, Dr S Cole, Mr J Horsnell and Mr R Sutton Royal United Hospital, Bath.
Clinical Outcome of Reconstruction With Tissue Expanders for Patients With Breast Cancer and Mastectomy Mitsui Memorial Hospital Department of Breast and.
Extranodal Extension on Sentinel Lymph Node Dissection: Why Should We Treat It Differently? Audrey Choi MD, Matthew Surrusco MD, Samuel Rodriguez MD, Khaled.
Role of Sentinel Lymph Node Biopsy in the Staging of Synovial, Epithelioid, and Clear Cell Sarcomas. Ugwuji N. Maduekwe, Francis J. Hornicek, Dempsey S.
SLN (Sentinel Lymph Node) And Breast (cancer)
SLNB Scenario Group Discussion Presented at: The Sentinel Lymph Node Biopsy Surgery Refresher Course October 29, 2010.
BREAST BRACHYTHERAPY OUTCOMES EVALUATION Margaret Pierce DNP, APRN, BC University of Tennessee Knoxville, Tennessee.
Adjuvant and Neoadjuvant Therapy in Non- Small Cell Lung Cancer Seminars in Oncology 2oo5;32 (suppl 2):S9-S15 Kyung Hee Medical Center Department of Thoracic.
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
Factors affecting failed localisation and false-negative rates of ex-vivo sentinel lymph node mapping in colorectal cancer. Sommariva A, Gnocato B, Tollot.
JHSGR 15/10/2016 Wong Lai Shan Tuen Mun Hospital
An introduction to Breast Cancer and Unmet Clinical Needs
The Use Of Sentinel Lymph Node Biopsy In MElanoma
A Model for Breast Services in North Wales
Sentinel lymph node and lymphatic mapping using indocyanine green for endometrium cancer: a case report. Suat Karatas, Veysel Sal, Emel Canaz, Meltem.
HER2 and estrogen receptor status drive decisions regarding the use of neoadjuvant chemotherapy Neil Love, MD1, Kimberly L Blackwell, MD2, Eleftherios.
Erica V. Bloomquist, MD Heather Wright, MD
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
بررسی اثرتشخیصی تکنسیوم 99 و متیلن بلو در بررسی گرفتاری گره لنفاوی sentinel در بیماران مبتلا به سرطان اندومتر کم خطر استاد راهنما: سرکار خانم دکترفریبا.
Treatment Overview: The Multidisciplinary Team
Presentation transcript:

Sentinel Node Biopsy : the way forward Hemant Singhal MS FRCSEd FRCS(Gen) FRCSC Consultant Surgeon Northwick Park & St Marks Hospital Senior Lecturer, Imperial College School Of Medicine These PowerPoint presentations are free to download only for academic purposes, with due acknowledgements to authors and this website.

MARCH 2005 HEMANT SINGHAL Introduction  Who should have it  When  How  Who will do it  What can we hope to achieve

MARCH 2005 HEMANT SINGHAL Background  95% of patients who present with breast cancer have apparently local disease.  Indirect features to suggest systemic involvement axillary lymph node metastasis tumour size, grade vascular or lymphatic invasion Her2neu status or p53 etc

MARCH 2005 HEMANT SINGHAL Preoperative evaluation of axilla  Clinical examination inaccurate, false negative rate of 39-45%  Mammography/ultrasound sensitivity of 70%  CT  MRI  PET  Ultrasound guided FNAC

MARCH 2005 HEMANT SINGHAL Rationale for axillary surgery  Status  Local control  Survival impact (B04) study 10 years 5-6% worse  There is no tumour size so small that one can ignore the axilla upto 20% for T1a

MARCH 2005 HEMANT SINGHAL Issues with axillary clearance  Maybe of limited therapeutic value  80% of patients maybe LN negative  Short term drains, seroma  Lymphoedema  Sensory loss in area of ICB  affects the lifestyle of a third

MARCH 2005 HEMANT SINGHAL Sentinel node concept  Ramon Cabanas  coined the term  lymphatic drainage in ca penis  Donald Morton: malignant melanoma

MARCH 2005 HEMANT SINGHAL Sentinel node concept  First draining lymph node  reflects the status of the axilla  can be identified and sampled

MARCH 2005 HEMANT SINGHAL SENTINEL NODE CONCEPT  sentinel node refers to the "node on watch.”  this node is the first node to receive cancer cells and that if this node is positive, there may be other positive nodes upstream.  The cancer cells don't "skip" and go to higher nodes.  If this node is negative, all the upstream nodes are negative 99 out of 100 times

MARCH 2005 HEMANT SINGHAL After a crime, you don't interrogate a bunch of people who were two blocks away; you focus on eye witnesses at the scene of the crime." —Marisa Weiss, M.D.

MARCH 2005 HEMANT SINGHAL Collective experience  ACS study ~ 5000 patients  ALMANAC ~UK study  18 other sizeable studies  88% LN detection  98% accuracy  7 series with 100% results

MARCH 2005 HEMANT SINGHAL Nuclear medicine aspects  Amount of radioactivity  dose of 0.1 mCi for same-day and 0.4 mCi for day-before injection  Preop scintigram useful initially know that there is a localised SNB abnormal pattern - Rotters, IM, breast

MARCH 2005 HEMANT SINGHAL Site of injection  SLN identified by intraparenchymal subdermal intradermal subareolar injections

MARCH 2005 HEMANT SINGHAL

MARCH 2005 HEMANT SINGHAL Surgical aspects  Identify blue lymphatics  track hot node  intraop palpation for involved node  gross disease can block localisation

MARCH 2005 HEMANT SINGHAL

MARCH 2005 HEMANT SINGHAL

MARCH 2005 HEMANT SINGHAL

MARCH 2005 HEMANT SINGHAL

MARCH 2005 HEMANT SINGHAL Inaccurate results  The scenario of a negative (non-cancerous) sentinel node and positive (cancerous) additional nodes in a patient can occur for several reasons, including:  The timing of the dye injections  The type of dye/tracers used  The presence of more than one sentinel node  The way in which the initial node was sectioned or stained in the pathology lab

MARCH 2005 HEMANT SINGHAL Poor candidates  palpable lymph nodes  Locally advanced breast cancer  multi-focal breast cancer  previous breast surgery (including breast reduction)  previous radiation therapy to the breast

MARCH 2005 HEMANT SINGHAL American College of Surgeons recommends  at least 30 snb followed by complete axillary node dissection,  with an 85% success rate in identifying the sentinel lymph node(s)  and a 5% or lower false positive rate.

MARCH 2005 HEMANT SINGHAL Tips & Tricks  Map with probe  3D mental map  Allow adequate time after blue dye inj  LN is invariably lower than you think  Persevere

MARCH 2005 HEMANT SINGHAL Can we stop after negative SNB  Axillary relapse, most studies have median FU that is too short  melanoma about 3-4%  expect 1% for breast  0.4% at median fu of 84 months Singhal 1996, MSKCC

MARCH 2005 HEMANT SINGHAL Should you go back after SNB+  39% have further involved nodes  this may be obvious at first op  intraoperative analysis cytology 10% false negative frozen section

MARCH 2005 HEMANT SINGHAL

MARCH 2005 HEMANT SINGHAL

MARCH 2005 HEMANT SINGHAL The important question  "HOW MANY lymph nodes are positive?"  not just "ARE lymph nodes positive?"